353235-63-9 Usage
Uses
Used in Pharmaceutical Industry:
4-(2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)aniline is utilized as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structural features, including the methoxyphenoxy and pyridin-3-ylmethyl groups, allow it to serve as a versatile building block for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
In the realm of chemical research, 4-(2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)aniline is employed as a valuable component in the creation of complex organic molecules. Its presence in these molecules can influence their reactivity, stability, and other chemical properties, making it an important tool for researchers in advancing the field of organic chemistry.
Used in Medicinal Chemistry:
Due to its demonstrated biological activity, 4-(2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)aniline is also considered for use in medicinal chemistry. It may contribute to the discovery and design of novel therapeutic agents, particularly those targeting specific biological pathways or receptors.
Check Digit Verification of cas no
The CAS Registry Mumber 353235-63-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,3,2,3 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 353235-63:
(8*3)+(7*5)+(6*3)+(5*2)+(4*3)+(3*5)+(2*6)+(1*3)=129
129 % 10 = 9
So 353235-63-9 is a valid CAS Registry Number.
353235-63-9Relevant articles and documents
Potentiators of glutamate receptors
-
Page 32, (2010/02/05)
The present invention relates to potentiators of metabotropic glutamate receptor function and specifically provides compounds of formula I, compositions thereof and methods of using the same.
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: Synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3- ylmethylamine
Johnson, Michael P.,Baez, Melvyn,Jagdmann Jr., G. Erik,Britton, Thomas C.,Large, Thomas H.,Callagaro, David O.,Tizzano, Joseph P.,Monn, James A.,Schoepp, Darryle D.
, p. 3189 - 3192 (2007/10/03)
This report describes recently discovered novel allosteric modulators of metabotropic glutamate2 (mGlu2) receptors. These pyridylmethylsulfonamides (e.g., 3) potentiate glutamate, shifting agonist potency by 2-fold. This effect was specific for mGlu2 (vs
